<SEC-DOCUMENT>0001104659-23-022228-index.html : 20230215
<SEC-HEADER>0001104659-23-022228.hdr.sgml : 20230215
<ACCEPTANCE-DATETIME>20230215081939
ACCESSION NUMBER:		0001104659-23-022228
CONFORMED SUBMISSION TYPE:	ARS
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20230215
DATE AS OF CHANGE:		20230215
EFFECTIVENESS DATE:		20230215

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Outlook Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001649989
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				383982704
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		ARS
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37759
		FILM NUMBER:		23633706

	BUSINESS ADDRESS:	
		STREET 1:		485 ROUTE 1 SOUTH
		STREET 2:		BUILDING F, SUITE 320
		CITY:			ISELIN
		STATE:			NJ
		ZIP:			08830
		BUSINESS PHONE:		6096193990

	MAIL ADDRESS:	
		STREET 1:		485 ROUTE 1 SOUTH
		STREET 2:		BUILDING F, SUITE 320
		CITY:			ISELIN
		STATE:			NJ
		ZIP:			08830

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Oncobiologics, Inc.
		DATE OF NAME CHANGE:	20150804
</SEC-HEADER>
<DOCUMENT>
<TYPE>ARS
<SEQUENCE>1
<FILENAME>tm233336d2_ars.pdf
<DESCRIPTION>ARS
<TEXT>
Document 1 - file: tm233336d2_ars.pdf

</DOCUMENT>
</SEC-DOCUMENT>